Urgent Care CentersCallBack-1NCT06194253
Reasons for Recourse and Diagnoses Associated With Early Recourse to an Emergency Structure After Initial Treatment
An observational study of Urgent Care Centers, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
To date, studies have been carried out on emergency department revisits but most are studies carried out in Anglo-Saxon territories. The studies carried out in France, for their part, concern the elderly geriatric population, or populations with specific pathologies such as child psychiatrists or patients with acute… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Urgent Care Centers
- How many people
- 500,000 participants
- Where
- 1 siteFrance
- Study dates
- 10 Jul 2023to Jul 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: - Major subject (≥18 years old) treated in the emergency room of the NHC or Hautepierre and having consulted the emergency room of one of the two sites 7 days after their first visit for an identical reason for recourse between January 1, 2017 to January 31, 2023.
Who may be able to join
- Major subject (≥18 years old)
- Subject treated in the emergency room of the NHC or Hautepierre and having consulted the emergency room of one of the two sites 7 days after their first visit for an identical reason for recourse between January 1, 2017 to January 31, 2023.
- Patient who has not expressed his opposition to the reuse of his data for scientific research purposes.
Who cannot join
- Patient having expressed his opposition to the retrospective reuse of his data
Trial locations and contacts
1 site in 1 country.
France1 site, 1 recruiting
- Recruiting
Service d'Accueil des Urgences - CHU de Strasbourg - France
Strasbourg, 67091
Sabrina Garnier Kepka, MD, 33 3 69 55 13 35, Sabrina.GARNIER-KEPKA@chru-strasbourg.fr
Aline CHENOU, Nurse, 33 3 69 55 13 35, aline.chenou@chru-strasbourg.fr
About this study
Official title: Evaluation of the Reasons for Recourse and Diagnoses Associated With Early Recourse to an Emergency Structure After Initial Treatment Followed by a Return Home
To date, studies have been carried out on emergency department revisits but most are studies carried out in Anglo-Saxon territories. The studies carried out in France, for their part, concern the elderly geriatric population, or populations with specific pathologies such as child psychiatrists or patients with acute heart failure, but not the general adult population. Nevertheless, these studies have shown that knowledge of the risk factors for early readmission of a patient makes it possible to carry out targeted prevention actions in order to reduce this early recourse rate.
However, in a context of increasing emergency flow and increasing tension in the field with limited healthcare resources, returning home and outpatient care are increasingly favored. However, these strategies only make sense if outpatient follow-up is organized when early reconsultation is possible for certain indications that remain to be determined. In this context, it would be interesting to have information on the reasons for which patients return to the emergency room early after initial treatment. This would indeed make it possible to consider carrying out preventive actions in the long term in order to reduce this revisit rate on the one hand and on the other hand to identify the signs of seriousness which should bring the patient back to the emergency room as soon as possible.
- Conditions
- Urgent Care Centers
- Keywords
- Emergency Department, Urgent Care Centers
- Medical subject headings
- Emergencies
What is being measured
The primary outcome is the main question the study is designed to answer.
Retrospective description of the most frequent reasons for recourse for which patients benefit from a new emergency consultation for the same reason within 7 days.
The aim of the study is to have information on the reasons for which patients return to the emergency room early after initial treatment. This would indeed make it possible to consider carrying out preventive actions in the long term in order to reduce this revisit rate on the one hand and on the other hand to identify the signs of seriousness which should bring the patient back to the emergency room as soon as possible.
Measured: up to 7 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2024
- Study start10 Jul 2023
- Primary completionJul 2025 (estimated)
- Study completionJul 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Urgent Care CentersStudies of the same condition, open and under way.
- More trials run by University Hospital, Strasbourg, FranceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 500,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06194253
- Sponsor's protocol ID
- 8958
- Acronym
- CallBack-1
- Status last verified
- Dec 2023
- First submitted
- 15 Dec 2023
- Last updated
- 8 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Reasons for Recourse and Diagnoses Associated With Early Recourse to an Emergency Structure After Initial Treatment Followed by a Return Home
- ClinicalTrials.gov ID
- NCT06194253
- Acronym / sponsor ID
- CallBack-1 / 8958
- Conditions
- Urgent Care Centers
- Keywords
- Emergency Department, Urgent Care Centers
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 500,000 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 10 Jul 2023 (actual)
- Primary completion
- Jul 2025 (estimated)
- Study completion
- Jul 2025 (estimated)
- First posted
- 8 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To date, studies have been carried out on emergency department revisits but most are studies carried out in Anglo-Saxon territories. The studies carried out in France, for their part, concern the elderly geriatric population, or populations with specific pathologies such as child psychiatrists or patients with acute heart failure, but not the general adult population. Nevertheless, these studies have shown that knowledge of the risk factors for early readmission of a patient makes it possible to carry out targeted prevention actions in order to reduce this early recourse rate.
However, in a context of increasing emergency flow and increasing tension in the field with limited healthcare resources, returning home and outpatient care are increasingly favored. However, these strategies only make sense if outpatient follow-up is organized when early reconsultation is possible for certain indications that remain to be determined. In this context, it would be interesting to have information on the reasons for which patients return to the emergency room early after initial treatment. This would indeed make it possible to consider carrying out preventive actions in the long term in order to reduce this revisit rate on the one hand and on the other hand to identify the signs of seriousness which should bring the patient back to the emergency room as soon as possible.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- - Major subject (≥18 years old) treated in the emergency room of the NHC or Hautepierre and having consulted the emergency room of one of the two sites 7 days after their first visit for an identical reason for recourse between January 1, 2017 to January 31, 2023.
Key inclusion criteria (3 listed)
- Major subject (≥18 years old)
- Subject treated in the emergency room of the NHC or Hautepierre and having consulted the emergency room of one of the two sites 7 days after their first visit for an identical reason for recourse between January 1, 2017 to January 31, 2023.
- Patient who has not expressed his opposition to the reuse of his data for scientific research purposes.
Key exclusion criteria (1 listed)
- Patient having expressed his opposition to the retrospective reuse of his data
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Retrospective description of the most frequent reasons for recourse for which patients benefit from a new emergency consultation for the same reason within 7 days.
Time frame: up to 7 days
The aim of the study is to have information on the reasons for which patients return to the emergency room early after initial treatment. This would indeed make it possible to consider carrying out preventive actions in the long term in order to reduce this revisit rate on the one hand and on the other hand to identify the signs of seriousness which should bring the patient back to the emergency room as soon as possible.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jan 2024.
Related trials for Urgent Care Centers
Recruiting
The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)
Lower Respiratory Tract Infection
RecruitingObservational study
Evaluation and Optimization of Telephone Triage Using Artificial Intelligence (AI) Models for the Detection of Demands for Time-dependent Pathology at the Emergency and Urgent Care Coordination Center (CCUE).
Chest Pain, Stroke Acute
Active, not recruiting
Improving Antibiotic Use for ARIs in Urgent Care Clinics
Antibacterial Agents, Ambulatory Care
Recruiting
To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy Pathway
Metastatic Spinal Cord Compression
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Urgent Care Centers, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Sabrina Garnier Kepka, MD (33 3 69 55 13 35, Sabrina.GARNIER-KEPKA@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Retrospective description of the most frequent reasons for recourse for which patients benefit from a new emergency consultation for the same reason within 7 days. (time frame: up to 7 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2024.